Opioid maintenance treatment: trajectories in and out of treatment

References

• Praveen KT, Law F, O’Shea J, et al. Opioid dependence. BMJ Clin Evid. 2011;2011:1015.
   PubMedGoogle Scholar
• Kosten TR, George TP. The neurobiology of opioid dependence: implications for treatment. Sci Pract Perspect. 2002;1:13–20.
   PubMedGoogle Scholar
• United Nations, Office on Drugs and Crime (UNODC). World drug report 2017. Vienna: UNODC; 2017. [August 20, 2018] Available at: https://www.unodc.org/wdr2017/index.html
   Google Scholar
• Folkhälsomyndigheten [The Public Health Agency of Sweden]. Den svenska Narkotikasituationen – En översikt över rapporteringen till EU:s narkotikabyrå [The drug situation in Sweden, Report to EMCDDA 2016. Solna: Folkhälsomyndigheten; 2018. Swedish. [November 1, 2018] Available at: https://www.folkhalsomyndigheten.se/contentassets/a777fa63c9b3497c92fe14c22493a9f3/den-svenska-narkotikasituationen-2015_webb-2017-1.pdf
   Google Scholar
• World Health Organization (WHO). The World Health Report 1999 – making a difference. Geneva: WHO; 1999.
   Google Scholar
• World Health Organization (WHO). Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva: WHO; 2009. [August 20, 2018] Available at: http://whqlibdoc.who.int/publications/2009/9789241547543_eng.pdf.
   Google Scholar
• Amato L, Davoli M, Perucci C, et al. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat. 2005;28:321–329.
   PubMed Web of Science ®Google Scholar
• Connock M, Juarez-Garcia A, Jowett S, et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess. 2007;11:1–171. iii-iv.
   PubMed Web of Science ®Google Scholar
• Aalto M, Visapää JP, Halm JT, et al. Effectiveness of buprenorphine maintenance treatment as compared to a syringe exchange program among buprenorphine misusing opioid-dependent patients. Nord J Psychiatry. 2011;65:238–243.
   PubMed Web of Science ®Google Scholar
• Otiashvili D, Piralishvili G, Sikharulidze Z, et al. Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior - Outcomes of a randomized trial. Drug Alcohol Depend. 2013;133:376–382.
   PubMed Web of Science ®Google Scholar
• Bates M, Pemberton DA. The effect of methadone prescribing in a clinic setting on the criminal activity of drug users. Scott Med J. 1996;41:173–175.
   PubMed Web of Science ®Google Scholar
• Cook C. The global state of harm reduction 2010: key issues for broadening the response. London: International Harm Reduction Association; 2010.
   Google Scholar
• Fareed A, Casarella J, Amar R, et al. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts. J Psychiatr Pract. 2009;15:227–234.
   PubMed Web of Science ®Google Scholar
• Darke S, Degenhardt L, Mattick RP. Mortality amongst illicit drug users: epidemiology, causes, and intervention. Cambridge: Cambridge University Press; 2007.
   Google Scholar
• Degenhardt L, Bucello C, Mathers B, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106:32–51.
   PubMed Web of Science ®Google Scholar
• Gryczynski J, Mitchell SG, Jaffe JH, et al. Leaving buprenorphine treatment: patients’ reasons for cessation of care. J Subst Abuse Treat. 2014;46:356–361.
   PubMed Web of Science ®Google Scholar
• Weinstein ZM, Kim HW, Cheng DM, et al. Long-term retention in office based opioid treatment with buprenorphine. J Subst Abuse Treat. 2017;74:65–70.
   PubMed Web of Science ®Google Scholar
• Bentzley BS, Barth KS, Back SE, et al. Patient perspectives associated with intended duration of buprenorphine maintenance therapy. J Subst Abuse Treat. 2015;56:48–53.
   PubMed Web of Science ®Google Scholar
• Reisinger HS, Schwartz RP, Mitchell SG, et al. Premature discharge from methadone treatment: patient perspectives. J Psychoactive Drugs. 2009;41:285–296.
   PubMed Web of Science ®Google Scholar
• Heikman PK, Muhonen H, Ojanperä IA. Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine. BMC Psychiatry. 2017;17:245.
   PubMed Web of Science ®Google Scholar
• Day E. Methadone treatment as palliation or an individualized process of recovery management? Addiction. 2012;107:953–954.
   PubMed Web of Science ®Google Scholar
• Gutwinski S, Bald LK, Gallinat J, et al. Why do patients stay in opioid maintenance treatment?. Subst Use Misuse. 2014;49:694–699.
   PubMed Web of Science ®Google Scholar
• Hiltunen AJ, Eklund C, Borg S. The first 38 methadone maintenance treatment patients in Stockholm: 15-year follow-up with a main focus on detoxification from methadone. Nord J Psychiatry. 2011;65:106–111.
   PubMed Web of Science ®Google Scholar
• Clausen T, Waal H, Thoresen M, et al. Mortality among opiate users: opioid maintenance therapy, age and causes of death. Addiction. 2009;104:1356–1362.
   PubMed Web of Science ®Google Scholar
• Bentzley BS, Barth KS, Back SE, et al. Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes. J Subst Abuse Treat. 2015;52:48–57.
   PubMed Web of Science ®Google Scholar
• Svensson B, Andersson M. Involuntary discharge from medication-assisted treatment for people with heroin addiction – patients’ experiences and interpretations. Nordisk Alkohol Nark. 2012;29:173–193.
   Google Scholar
• Johnson B. Metadon på liv och död: en bok om narkomanvård och narkotikapolitik i Sverige [Methadone–A Matter of Life and Death]. Lund: Studentlitteratur; 2005. (Swedish).
   Google Scholar
• Socialstyrelsen [National Board of Health and Welfare]. Socialstyrelsens föreskrifter och allmänna råd om läkemedelsassisterad behandling vid opiatberoende [Code of statues regulating opiate-assisted treatment] SOSFS 2009:27 (M). Stockholm: Socialstyrelsen; 2009. (Swedish).
   Google Scholar
• Monwell B, Gerdner A. Opiates versus other opioids – are these relevant as diagnostic categorizations? Heroin Addict Relat Clin Probl. 2017;19:39–48.
   Web of Science ®Google Scholar
• Monwell B, Bulow P, Gerdner A. Type of opioid dependence among patients seeking opioid substitution treatment: are there differences in background and severity of problems? Subst Abuse Treat Prev Policy. 2016;11:23.
   PubMed Web of Science ®Google Scholar
• Monwell B, Johnson B. Opiatregeln - i konflikt med vetenskap, yrkesetik och klinisk erfarenhet och hur den kom att hanteras i praktiken. [The Opiate rule - in conflict with science, occupational ethics and clinical experience and how it was handled in practice]. Forthcoming 2018. (Swedish).
   Google Scholar
• Socialstyrelsen [National Board of Health and Welfare]. Socialstyrelsens föreskrifter och allmänna råd (HSLF-FS 2016:1) om läkemedelsassisterad behandling vid opioidberoende [Code of statues (HSLF-FS 2016:1) regulating opioid-assisted treatment]. Stockholm: Socialstyrelsen; 2016. (Swedish). [August 20, 2018]. Available at: http://www.socialstyrelsen.se/sosfs/2016-1
   Google Scholar
• Nyström S, Zingmark D, Jäderland A. ASI-manualen: anvisningar till ASI Grund och ASI Uppföljning [ASI Manual: Instructions for ASI Basic and ASI Follow-up]. Stockholm: Socialstyrelsen; 2009. (Swedish).
   Google Scholar
• Svensson E. Teaching: a way of implementing statistical methods for ordinal data to researchers. J Math Syst Sci. 2012;2:8–12.
   Google Scholar
• Godfrey MM. Improvement capability at the front lines of healthcare: helping through leading and coaching [Dissertation]. Jönköping: University, School of Health and Welfare; 2013.
   Google Scholar
• Avdic A, Svensson E. Svenssons method (Version 1.1). [August 20, 2018]. Available at http://avdic.se/svenssonsmethodenglish.html
   Google Scholar
• Cumberbatch Z, Copersino M, Stitzer M, et al. Comparative drug use and psychosocial profiles of opioid dependents applying for medication versus medication‐free treatment. Am J Drug Alcohol Abuse. 2004;30:237–249.
   PubMed Web of Science ®Google Scholar